Clinical trial Recruiting at 1 site Interventional Ages 18 to 75 Women only

Comparing cold dissection and electrocautery in nipple-sparing mastectomy with reconstruction

Official title: Necrosis After Cold Dissection Versus Electrocautery Dissection in Endoscopic Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction: A Prospective Randomized Controlled Trial

Run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06024187 · Data updated 2026-11-12

This study is testing whether using cold dissection instead of electrocautery during nipple-sparing mastectomy can lead to fewer complications and better cosmetic results for patients getting breast reconstruction.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexWomen only
Enrollment566 (estimated)
SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedNovember 23, 2022
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedFebruary 13, 2025
Trial IDNCT06024187 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women with breast tumors smaller than 5 cm who are eligible for nipple-sparing mastectomy.

Probably not a fit

Patients with evidence of nipple-areola complex involvement, chest wall or skin invasion, or severe comorbid conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of cold dissection versus electrocautery dissection in patients undergoing nipple-sparing mastectomy followed by immediate implant-based reconstruction. The study focuses on evaluating whether cold dissection can reduce the incidence of ischemia necrosis and other surgical complications, while also improving aesthetic outcomes. Participants will be randomly assigned to receive one of the two surgical techniques, and their postoperative results will be closely monitored. The trial is based on previous findings suggesting that cold dissection may lead to better outcomes compared to electrocautery.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and aesthetic results for patients undergoing mastectomy and reconstruction.

How similar studies have gone: Previous studies have indicated that cold dissection may reduce complications compared to electrocautery, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Tumor smaller than 5 cm
* No evidence of NAC, skin or chest wall invasion.
* The general inclusion criteria or pre-requisite for nipple sparing mastectomy apply to E-NSM as well.

Exclusion Criteria:

* Patients with apparent NAC involvement, chest wall or skin invasion, inflammatory breast cancer, locally advanced breast cancer or severe comorbid conditions or poor performance status assessed by the primary physicians, such as heart disease, renal failure, liver dysfunction, and poor performance status as assessed by the primary physicians.

Where it's running

  • Shicheng Su
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Improved Facial Skin Quality After VYC-12L for Breast Cancer Survivors

    This study tests whether intradermal injections of VYC-12L can improve facial skin quality and quality of life in adults who have completed breast cancer treatment.

    Recruiting Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · Murcia, Murcia · NCT07917117

  • Breast cancer subtypes and outcomes in Colombian women

    This study looks back at medical records of women with breast cancer to see how different molecular subtypes relate to survival and recurrence in a single Colombian hospital.

    Recruiting Fundación Santa Fe de Bogota · Bogotá, Bogota D.C. · NCT07856225

  • Multimodal psychosomatic symptom care for breast cancer: personalized acupuncture care guided by shared decision-making

    This study tests whether personalized acupuncture options (manual acupuncture, ear acupuncture, or both) can help women with breast cancer who have anxiety, sleep problems, or fatigue, compared to routine nursing care.

    Recruiting at 3 sites First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · Tianjin and 2 other locations · NCT07763587

  • Slow Jogging for Breast Cancer Survivors

    This study tests whether a 12-week slow jogging program helps sleep quality in women who have completed breast cancer treatment.

    Recruiting Mackay Memorial Hospital · Taipei, Taipei City · NCT07757763

  • Methylscape test in body fluids for multi-cancer detection in Colombia

    A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.

    Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07741435

  • Benchmarking AI language models against tumor boards for oncology treatment decisions

    This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.

    Recruiting Assistance Publique - Hôpitaux de Paris · Boulogne-Billancourt and 4 other locations · NCT07739121

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.